Impaired antifungal responses due to the missense mutation of another IBD-related gene CX3CR1 in myeloid cells lead to an increase in intestinal and extraintestinal inflammatory diseases [2, 170]. Here, CX3CR1 is linked to inflammatory bowel disease.